Terms: = Kidney tumors AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Treatment
48 results:
1. The BAP1 nuclear deubiquitinase is involved in the nonhomologous end-joining pathway of double-strand DNA repair through interaction with DNA-PK.
Sato H; Ito T; Hayashi T; Kitano S; Erdjument-Bromage H; Bott MJ; Toyooka S; Zauderer M; Ladanyi M
Oncogene; 2024 Apr; 43(15):1087-1097. PubMed ID: 38383726
[TBL] [Abstract] [Full Text] [Related]
2. Predictive and prognostic biomarkers in urological tumours.
Cimadamore A; Franzese C; Di Loreto C; Blanca A; Lopez-Beltran A; Crestani A; Giannarini G; Tan PH; Carneiro BA; El-Deiry WS; Montironi R; Cheng L
Pathology; 2024 Mar; 56(2):228-238. PubMed ID: 38199927
[TBL] [Abstract] [Full Text] [Related]
3. Ocular metastasis from renal malignancies - A comprehensive review.
Jindal A; Kapatia G; Gupta G
Indian J Ophthalmol; 2023 Oct; 71(10):3281-3289. PubMed ID: 37787223
[TBL] [Abstract] [Full Text] [Related]
4. Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial.
Rodler E; Sharma P; Barlow WE; Gralow JR; Puhalla SL; Anders CK; Goldstein L; Tripathy D; Brown-Glaberman UA; Huynh TT; Szyarto CS; Godwin AK; Pathak HB; Swisher EM; Radke MR; Timms KM; Lew DL; Miao J; Pusztai L; Hayes DF; Hortobagyi GN
Lancet Oncol; 2023 Feb; 24(2):162-174. PubMed ID: 36623515
[TBL] [Abstract] [Full Text] [Related]
5. treatment Strategies for Hereditary kidney Cancer: Current Recommendations and Updates.
Singh S; Chaurasia A; Gopal N; Malayeri A; Ball MW
Discov Med; 2022; 34(173):205-220. PubMed ID: 36602871
[TBL] [Abstract] [Full Text] [Related]
6. The BRCAness Landscape of Cancer.
Guo M; Wang SM
Cells; 2022 Dec; 11(23):. PubMed ID: 36497135
[TBL] [Abstract] [Full Text] [Related]
7. Roles of DNA damage repair and precise targeted therapy in renal cancer (Review).
Lai Y; Li Z; Lu Z; Zheng H; Chen C; Liu C; Yang Y; Tang F; He Z
Oncol Rep; 2022 Dec; 48(6):. PubMed ID: 36263616
[TBL] [Abstract] [Full Text] [Related]
8. BAP1 maintains HIF-dependent interferon beta induction to suppress tumor growth in clear cell renal cell carcinoma.
Langbein LE; El Hajjar R; He S; Sementino E; Zhong Z; Jiang W; Leiby BE; Li L; Uzzo RG; Testa JR; Yang H
Cancer Lett; 2022 Oct; 547():215885. PubMed ID: 35995140
[TBL] [Abstract] [Full Text] [Related]
9. Impact of the app-based and nurse-led supportive care program AKO@dom on dose intensity of oral-targeted therapies in patients with metastatic renal cell cancer: a multicentric observational retrospective study.
Gaillard V; Lhuillier A; Bigot C; Pierard L; Trensz P; Burgy M; Schuster C; Malouf G; Fritsch A; Lang H; Tricard T; Borchiellini D; Geoffrois L; Barthelemy P
Support Care Cancer; 2022 Aug; 30(8):6583-6591. PubMed ID: 35484315
[TBL] [Abstract] [Full Text] [Related]
10. Management of a Prostate Cancer Patient With Inherited Germline brca1 and BRCA2 Mutations: A Case Report.
Hemal S; DeWitt-Foy M; Klein EA
Urology; 2021 Jul; 153():129-131. PubMed ID: 33556450
[TBL] [Abstract] [Full Text] [Related]
11. Cabozantinib real-world effectiveness in the first-through fourth-line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Gan CL; Dudani S; Wells JC; Donskov F; Pal SK; Dizman N; Rathi N; Beuselinck B; Yan F; Lalani AA; Hansen A; Szabados B; de Velasco G; Tran B; Lee JL; Vaishampayan UN; Bjarnason GA; Subasri M; Choueiri TK; Heng DYC
Cancer Med; 2021 Feb; 10(4):1212-1221. PubMed ID: 33463028
[TBL] [Abstract] [Full Text] [Related]
12. Hereditary leiomyomatosis and renal cell carcinoma: a case series and literature review.
Chayed Z; Kristensen LK; Ousager LB; Rønlund K; Bygum A
Orphanet J Rare Dis; 2021 Jan; 16(1):34. PubMed ID: 33461594
[TBL] [Abstract] [Full Text] [Related]
13. Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study.
Wang K; Wu Z; Wang G; Shi H; Xie J; Yin L; Xu T; Mao W; Peng B
Int Braz J Urol; 2021; 47(2):333-349. PubMed ID: 33284535
[TBL] [Abstract] [Full Text] [Related]
14. Folliculin deficient renal cancer cells exhibit brca1 A complex expression impairment and sensitivity to PARP1 inhibitor olaparib.
Zhang Q; Xu Y; Zhang Z; Li J; Xia Q; Chen Y
Gene; 2021 Feb; 769():145243. PubMed ID: 33069804
[TBL] [Abstract] [Full Text] [Related]
15. Impact of Time to Surgery and Surgical Delay on Oncologic Outcomes for Renal Cell Carcinoma.
Shiff B; Breau RH; Patel P; Mallick R; Tanguay S; So A; Lavallée L; Moore R; Rendon R; Kapoor A; Pouliot F; Finelli A; Bhindi B; Lattouf JB; Basappa N; Wood L; Heng D; Bjarnason G; Drachenberg D
J Urol; 2021 Jan; 205(1):78-85. PubMed ID: 32614274
[TBL] [Abstract] [Full Text] [Related]
16. Impact of Hospital Case Volume on Outcomes Following Radical Nephrectomy and Inferior Vena Cava Thrombectomy.
Freifeld Y; Woldu SL; Singla N; Clinton T; Bagrodia A; Hutchinson R; Lotan Y; Margulis V
Eur Urol Oncol; 2019 Nov; 2(6):691-698. PubMed ID: 31411983
[TBL] [Abstract] [Full Text] [Related]
17. Evolving Role of Genomics in Genitourinary Neoplasms.
Devitt ME; Dreicer R
Acta Med Acad; 2019 Apr; 48(1):68-77. PubMed ID: 31264434
[TBL] [Abstract] [Full Text] [Related]
18. Two synchronous malignancies: nodular melanoma and renal cell carcinoma in a patient with an underlying germline
Snow A; Ricker C; In GK
BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31227566
[TBL] [Abstract] [Full Text] [Related]
19. Carcinoid tumor of lung and BRCA mutation: a case report.
Shariff MZ; Curras-Martin D; Campbell N; Gupta V; Mikhail JD; Levitt MJ; Hossain MA
J Med Case Rep; 2019 May; 13(1):132. PubMed ID: 31039815
[TBL] [Abstract] [Full Text] [Related]
20. Intraocular Concentrations of Cytokines and Chemokines in a Unique Case of Nivolumab-Induced Uveitis.
Yoshida M; Kunikata H; Nakazawa T
Ocul Immunol Inflamm; 2020 Aug; 28(6):850-853. PubMed ID: 31012778
[TBL] [Abstract] [Full Text] [Related]
[Next]
